Potassium Phosphate Pediatric Dose — Electrolyte Replacement
Potassium phosphate is an intravenous electrolyte solution that delivers both phosphate and potassium, correcting hypophosphatemia while simultaneously addressing associated hypokalemia. It acts by directly replenishing intracellular and extracellular phosphate stores essential for energy metabolism, oxygen delivery, and cellular function. It is commonly indicated in pediatric patients with moderate-to-severe hypophosphatemia, including those in the PICU, post-operative settings, or with refeeding syndrome.
Pediatric Dosing
- Dose: 0.2–0.4 mmol/kg IV per dose, infused over 4–8 hours
- Maximum single dose: 15 mmol
The dose is selected based on the severity of hypophosphatemia and the clinical context. Lower doses (0.2 mmol/kg) are appropriate for mild-to-moderate deficits or in patients at risk for fluid overload; higher doses (0.4 mmol/kg) may be used for more significant depletion under close monitoring.
Worked example: For a 20 kg child: 20 × 0.3 mmol/kg = 6 mmol of potassium phosphate IV over 4–8 hours. For a 40 kg adolescent at 0.4 mmol/kg: 40 × 0.4 = 16 mmol — capped at the maximum of 15 mmol per dose. Consult institutional protocol for repeat dosing intervals and reassessment timing.
Indications and Clinical Context
Intravenous potassium phosphate is indicated for the treatment of hypophosphatemia in pediatric patients who cannot tolerate or absorb oral phosphate supplementation. Clinical scenarios include refeeding syndrome, prolonged parenteral nutrition, diabetic ketoacidosis recovery, severe burns, and critical illness with increased phosphate consumption. Hypophosphatemia can impair myocardial contractility, diaphragmatic function, and erythrocyte oxygen delivery (via 2,3-DPG depletion), making prompt correction important in the PICU setting.
The IV route is preferred when serum phosphorus is critically low, when the patient is NPO, or when gastrointestinal absorption is unreliable. Dosing and reassessment should be guided by serial serum phosphorus and potassium levels, as each mmol of potassium phosphate also delivers approximately 1.5 mEq of potassium.
Administration and Monitoring
Potassium phosphate must be administered as a slow IV infusion over 4–8 hours; rapid infusion risks hypocalcemia, hypotension, and cardiac arrhythmias. It should be diluted in a compatible IV fluid (typically 0.9% NaCl or dextrose-containing solutions) per institutional pharmacy guidance. The potassium co-load must be factored into the patient’s total potassium intake to avoid hyperkalemia, particularly in patients with renal impairment.
- Monitor serum phosphorus, potassium, calcium, and magnesium before and after each dose
- Use with caution in patients with renal insufficiency, hyperkalemia, or hypercalcemia
- Avoid extravasation — potassium phosphate is irritating to peripheral veins; central venous access is preferred for concentrated solutions
- Consult institutional protocol for concentration limits, compatible diluents, and repeat dosing intervals
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.